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BACKGROUND 
The situation in Mrica 
The prevalence of HIV infection shows considerable 
variability within Africa among high risk urban groups 
(mainly prostitutes and sexually transmitted disease clinic 
patients). It is over 35 % in Rwanda, Uganda, Zambia, 
Kenya, Malawi, Tanzania and Zaire 1 , 10-35 % in most west 
and central African countries, 2.5-10 % in South Africa, 
Mozambique, Cameroon and Benin, 0.3-2.5 % in Bot-
swana and Senegal, and less than 0.3 % in Somalia and 
the north African countries1.2. HIV infection among low 
risk urban groups is much less common and the highest 
HIV seroprevalence (more than 10 %) has been reported 
from Uganda and Zambia!. ." .. 
Heterosexual and perinatal transmissionaretbemain 
routes of spread ofHIV in Sub-Sabaran Atl.,~.~ .. 
sion of the virus through ~t milk 
investigated and tentatively quanlti8ed"~; 
The purpose of this paper is to summarize briefly the 
studies completed by theJHU-MOH project to date and 
to draw conclusions and recommendations from these 
investigations. Further details on these studies can be 
found in papers by the JHU-MOH project cited through-
out the text. 
MATERIALS AND METHODS 
The study design 
At the outset, a small cross-sectional study was con-
ducted to determine HIV·1· among 
women ~teBdingpr.natal v .. iu . Blantyre 
and HPapi\tl the 
fol-
transmission has the' for COlIYWIlelIti rlle"%: ••• ;;;·····.Eii 
implications regarding infant feeding . . 
developing societies. It has been estimated' thatbytfte'''' • 
early 1 990s about 2.5 million women of childbearing age 
in Africa were infected with the virus; these women gave 
birth to about 2 million infants of whom about 500,000 
infants (25 %) were infected with HIV5. These figures 
highlight the challenge posed by HIV on the health, 
social, and economic development and the demographic 
structure of Sub-Saharan Africa. 
The JHU.MOH Research Project 
The current research project commenced in 1989 and 
is a collaborative effort between the Johns Hopkins Uni-
versity School of Hygiene and Public Health in Baltimore, 
U.S.A. and the Malawi Ministry of Health. The project, 
which included studies on different aspects of HI V infec-
tion, was approved by scientific and ethical committees 
in Malawi and in the U.S.A. A resident research team at 
Queen Elizabeth Central Hospital (QECH) in Blantyre 
conducts the different activities of the project and acts as 
a liaison between scientists in the country and abroad. 
a Johns Hopkins University Research Project, b Malawi College of 
Medicine, C Ministry of Health, Malawi 
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b.i.Ologu: .. ; . a .. 00 ... beha~~_. 'aofHIV ser'!fonver-
. Sl~~:.s.=t.Q~~n:;u~~e ofJlfV serol-
ogy tests from oegautl4., .- . ... lCl'oconverter is 
a person who dilpta.Yf' .•. . '. 
Data collection and ph,.ncal en., ..... 
After obtaining informed coment.~ographic 
information and medical, repro(l1K;Y~ ;~d pregnancy 
history were obtained. The interviC\YI ~ conducted by 
trained study workers during the first antenatal viSi~ after 
delivery and at subsequent postnatal visits .. Home tracing 
of women lost to follow-up was dope when necessary. At 
each visit Lhorough physical and·.peculum aided pelvic 
examinations were conducted by trained midwives and 
appropriate specimens were collected .. 
Specimen collection 
Vaginal fluid, cervical swabs, Pap smear and cervico-
vaginal lavage for human papilloma virus (HPV) were 
routinely collected at regular intervals. Blood was col-
lected for HIV testing, syphilis serology, white blood 
count and differential, and lymphocyte immunopheno-
lyping. Breast milk specimens, and, on a limited number 
of women, placental sections were collected. Colposcopic 
examination was conducted by a gynaecologist on women 
who had an abnormal Pap smear or a positive HPV result. 
From infants, blood was collected at age 12 and 18 
months for HIV-l testing, and malaria smears were rou-
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Laboratory analyses 
A group of trained technicians conducted serum analy-
sis using ELISA test (Wellcozyme, Wellcome Diagnostics) 
for the detection of antibody to HIV-1. The procedures 
followed were regularly assessed for quality control and 
assurance. All specimens were initially screened by 
ELISA and those testing positive for HIV-I were con-
firmed by Western blot (Bio-Rad Laboratories). Syphi-
lis serology was performed using the rapid plasma 
reagin (RPR) test for screening and fluorescent tre-
ponemal antibody test (ITA) for confirmation. Micro-
scopic examinations were done on vaginal wet mounts 
to detect T. vaginalis, yeast forms, clue cells and white 
blood cells. Cervical swabs for N. gonon'hea (GC) were 
inoculated inte> culture media prepared in the labora-
tory in Blantyre and placed in candle extinction jars. 
The jars were incubated at 36° C for 24-48 hours and 
isolates were presumptively identified by colony and 
Gram stain morphology and by oxidase reaction. Da-
cron cervical swabs for chlamydial fluorescent antibody 
test (Microtrak Direct Specimen Test) were applied to 
the slide, fixed with methanol, and frozen at 20° C for 
later processing in the United States. HPV detection 
was done by polymerase chain reaction (PCR) on cerv-
icovaginal cells obtained by lavage. Samples were 
shipped to the Johns Hopkins University in the U.S. 
where analysis was done. WBC counts were followed 
by lymphocyte immunophenotyping using fluorescent 
monoclonal antibodies (Becton Dickinson). Flow cy-
tometric analysis of CD4 and CD8 lymphocytes and 
white blood cell differentials were done with a 
FACScan (Becton Dickinson) available at theJHU labo-
ratory in QECH. 
Data management and analysis 
Data collected were systematically checked for com-
pleteness and entered onto micro-computers in Blan-
tyre. After further data management, univariate and 
multivariate analyses were conducted as appropriate. 
These included descriptive statistics, rates of morbidity 
and mortality, measures of associations, and confi-
dence intervals. Survival analysis was used to determine 
rates of events, and multiple logistic regression was 
used for adjustment of potential confounders, ap-
praisal of interactions and assessment of major predic-
tors of outcome. 
RESULTS AND DISCUSSION 
Prevalence/Incidence of HIV-I 
Of 6605 women who were interviewed and tested at 
QECH between October 1989 and October 1990, 1505 
(22.8 %) were HIV-l seropositive. For comparison, the 
seroprevalence of HIV-l among pregnant women at-
tending antenatal clinics at QECH in Blantyre for the 
period 1985-1993 and at KCH for the period 1987-1990 
is shown in Table I. There is a clear trend of increase 
in prevalence over time. These estimates are cross-sec-
tional in nature and should not be extrapolated with-
out caution to other urban or rural communities of 
Malawi. 
7 
Table I. Sero/Jrt!valellce of 1-J/V-I among pregna7!l women attending 
antenatal clinir-s in QECH and KCH, 1985-1993. 
QECH KCH 
MOlllh/Year # tested Prevalellce % # tested Prevalence % 
Jun.1985 200 2.0 
JUII. 1987 85 8.2 184 8.2 
Dec. 1988 247 18.6 214 16.4 
Oct. 1990 845 21.9 201 17.9 
Oct. 1991 404 25.9 
Jul. 1992 291 27.2 
Jan. 1993 437 31.6 
The point estimates of the incidence of HI V-I serocon-
version at QECH and KCH for the period 1987 to 1989 
was estimated as 10 % and 7.5 %, respectively6. The rate 
of HIV -1 seroconversion after delivery among a cohort of . 
694 HIV-l seronegative mothers who were enroled at 
delivery is shown in Table 2. The rate of HIV-J serocon-
version increases over time suggesting that women in 
Malawi are at increased risk during the postnatal period. 
The lower rates in the first year could be due to the 
traditional pl"actice of sexual abstinence in the first six 
months after delivery in this community'. 
Table 2. RaU oj HIY-l aeroconvenioll aft.,. deli.,.", QECH, Blantyre 
1989-1992. . 
HIV-l Sel'o- Per/iOD-
Months eQ!l.vertell Sell\ellter· Rate (%) 
O.u 5 559.4 0.90 
7-12 9 473.5 1.90 
13-18 " 10 406.8 2.46 
19-24 11 253.5 4.34 
" 
• Number of persons at risk of HIV-I seroconversion X Number of 
aill-niontb period. (semester) in which these penons al'e at risk. All 
penon. were considered at risk of HIV-l seroconversion until the 
time they seroconverted. 
Rates of sexually transmitted diseases (STDs) 
The incidence of gonorrhoea, trichomoniasis, genital 
ulcers and genital warts among the cohort ofr644 HIV-I 
seropositive and 677 HIV-l seronegative women is shown 
in Table 3. The cumulative incidence of these diseases 
was significantly higher in HIV-l seropositive than in 
HIV-l seronegative women. The higher rate of new STDs 
in HIV-l infected women may represent increased sus-
ceptibility, increased exposure or, in the case of genital 
warts, compromised immune status of the woman. The 
consistelll relationship between STDs and HIV-J empha-
sizes the need for a coordinated intervention approach 
to optimize management and control of STDs8. 
Table J. llicidelice of sexllally t,.allsmitted dueases among HIV-1 
seropositive and serollegative women, QECH, Blantyre November 1989 to 
November 1992. 
STD HIV-l positive HIV-l negative P-value 
% % 
GOllorrhoea ]9.8 7.9 <0.001 
Tdchollloniasis 51.3 35.6 0.009 
Genital ulcer 26.9 9.3 <0.001 
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Risk r.ctors associated with HIV-I seropositivity and 
serocoDversion 
Sexually transmitted diseases. In the cross-sectiorpl 
study, genital warts were found in 124/1479 (8 %) HIV-l 
seropositive vs 110/5031 (2 %) HIV-l seronegative 
women (odds rati0=4.1). Genital ulcer disease was pre-
sent in 166/1479 (11 %) HIV-l seropositive vs 277/5031 
(5 %) HIV-l seronegative women (odds ratio=2.2). Cervi-
cal ectopy was not associated with HIV seropositivity 
(ectopy was found in 31 % of HIV-l infected vs 28 % of 
HIV-l uninfected women). Clinical indicators of cervicitis 
(abnormal cervical discharge and cervical bleeding) were 
more common in HIV-l infected women, regardless of 
the presence of cervical infection, making these clinical 
indicators less useful in STDs evaluation of HIV-l in-
fected women9• 
High socio-economic status and STDs. Women of 
higher socio-economic status (SES) and women with cur-
rentSTDs were both more than twice as likely to be HIV-l 
infected. Higher SES was defined as husband's education 
of more than eight years. HIV -1 seroprevalence increased 
with SES, from 26 % to 42 % in women with diagnosed 
STDs and from 11 % to 22 % in women without STD 
diagnosis. The presence of diagnosed STDs approxi-
mately doubled the risk of having HIV-l infection irre-
spective of SES: 22 % to 42 % among high SES women 
and 11 % to 26 % among low SES women. STDs were 
positively associated with HIV-l infection (OR=2.73), but 
not with higher SES. These results suggest that women 
and their husbands/partners of higher SES adopt more 
high risk behaviours which predispose to HIV-l infection. 
Such behaviours are apparently encouraged by their eco-
nomic ability to seek medical care and treatment for 
bacterial STDslO. The fmdings have policy implications 
related to lack of adequate knowledge on transmissions 
of HIV-l even among the "eliteM groups of higher SES. 
Therefore intervention strategies to control STDs should 
include all segments of the population. 
Vaginal agents. Use of traditional vaginal agents 
(desiccants, leaves, stones, etc.) for treatment of itching 
and vaginal discharge or for tightening purposes were 
investigated as risk fact;ors for HIV-l infection because 
these practices have been reported to be associated 
with HIV-l infection in other African countriesll•12• 
Forty five percent of women attending the antenatal 
clinic at QECH reported self-treatment of vaginal dis-
charge and itching and 13 % (886) reported using 
vaginal agents for tightening of the vaginal wall. Of 
HIV-l infected women 17 % used intra-vaginal agents 
for treatment in comparison to 14 % of uninfected 
women (OR=1.2; p=O.OI). Although the relative risk is 
small, the risk attributable to these agents could be 
substantial due to their fairly common use in the popu-
lation studiedu . 
Human papilloma virus (HPV) infection and cervical 
lesions in HIV-l infected women. Samples on 286 post-
partum women were examined to document the associa-
tion between HPV infection, squamous intra-epithelial 
lesion (SIL) and HIV-l infection. Cervical SIL was de-
tected in 13 % of HIV-l seropositive vs 6 % HIV-l 
seronegative women. SIL increased with decreasing CD4 
cells among HIV-l infected women (p trend=0.06). HPV 
was detected in 20 % of the HIV-l seronegative, but in as 
high as 58 % of HI V-I seropositive women with less than 
9 
300 CD4 cells. Among women followed longitudinally, 
cervicovaginal lavage specimens were collected on 104 
HIV-l seropositive and seronegative women at two time 
points approximately one year apart. Seropositive 
women were more likely than seronegative women to 
have HPV newly detected and to show persistent HPV in 
the follow-up samples (Table 4). Genital neoplasms may 
become more frequen t in women of high HIV prevalence 
areas. Therefore, closer gynaecologic screening of high 
risk women in these areas is warranted as cervical cancer 
is becoming a major cause of mortality in Africa 
(Chiphangwi et aI, unpublished data). 
Table 4. Human Papilloma Virus (HPV) exprvsion among HIV-l 
leropontive and HIV-l seronegative women in two follow-up visits, QECH 
1992. 
HPV status HIV-l Sero- HIV-l Se.·o-
From To positive negative P-Value 
HPV(-) HPV(+) 16/30 (53%) 13/48 (27%) 0.02 
HPV(+) HPV(-) 3/13 (23%) 9/13 (69%) 0.02 
HPV(+) HPV(+) 10/13 (77%) 4/13 (31%) 0.02 
HPV(-) HPV(-) 14/30 (47%) 35/48 (73%) 0.02 
Maternal HIV-l p-24 antigen and vertical transmission. 
Using a quantitative p-24 antigen ELISA test, 123 serum 
specimens from third trimester HIV-l serostatus known 
women were tested to determine whether the level of 
maternal p-24 antigenemia was correlated with HIV-l 
transmission to their babies. These 123 women included 
54 HIV-l seropositive women with HIV-l infected babies, 
49 HIV-l seropositive women with HIV-l uninfected 
babies, and 20 HIV-l negative women as controls. The 
HIV-l serostatus of the baby was established at 12 months 
and confirmed at 18 months of age. Eighteen of26 HIV-l 
seropositive mothers (69 %) with detectable p-24 antigen 
had infected infants, whereas 36 of 77 HIV-l seropositive 
mothers (47 %) without detectable p-24 antigen had 
infected infants (OR=2.6, p=0.04). These findings suggest 
that transmission of the virus to the fetus occurs either 
very early after infection or late in the course of the 
disease i.e., when there are not enough antibodies to the 
HIV-l p-24 antigen. 
InfaM mortality and spontaneous abortion. A history 
of childhood mortality in the previous pregnancy was 
present in 35 % HIV -1 seroJ>6SU:.ive vs 15 % HIV -1 serone-
gative mothers. Infant mortality and under three year 
mortality was 77 per 1000 and 119 per 1000, respectively, 
in seronegative mothers. For seropositive mothers, how-
ever, mortality rates were higher; 171 per 1000 infant 
mortality and 292 per 1000 under three year mortality. 
Spontaneous abortion was reported more often by HIV-l 
seropositive than seronegative mothers (15 % vs 7 %), and 
was associated with history of previous abortion, history 
of STDs, confirmed syphilis serology and young maternal 
agel4• 
The mortality experience and associated factors dur-
ing the first year were studied on the babies of691 HIV-l 
infected and 687 uninfected mothers in the cohort study. 
Infant mortality was significantly higher for babies of 
HIV-l seropositive mothers than for babies of HIV-l 
seronegative mothers (Table 5). Short gestational age was 
associated with lower survival probabilities and occurred 










































mothers (13.9 %) than in infants of seronegative mothers 
(5.4 %). Pneumonia, fever, failure to thrive and diarrhoea 
were the most common proximate causes of death be-
sides prematurity/low birth weight in babies of seroposi-
tive mothers. Excess mortality among infants aged 3-12 
months of serogositive mothers could be attributed to 
HIV-I infection 5. 
Table 5. Survival probabilitia (and Standard erron)forinfanu of HIV-l 
















In a related analysis, of 367 babies born to HIV-I 
seropositive mothers who were alive and tested for 
HIV-I antibody at 12 months or after, 84 (22.9 %) were 
positive by ELISA and Western blot testing. Combining 
this information with the probability of death before 
12 months for babies born to seropositive and serone-
gative mothers (0.198 and 0~056, respectively), the 
mother-to-infant HIV transmission rate was estimated 
as 34.5 %. In this population, all babies who were 
HIV-I seropositive at 12 months (N=51) were also 
HIV-I seropositive at 18 months or later, suggesting 
that loss of maternal antibodies to HIV -I occurs by age 
12 months. 
Risk factors for incident HIV infection. Tile risk 
factors with the strongest associationS with HIV-llSt!tO-
conversion among WOmen who~ere p~o , •• ' 
gative were trichomorift~.i.(OJt.~1'trt;~":¢11 
1.11-12.70), sexuaHrtterc~Witt'1t ,', ',' , ' 
using condom (OR-&;50,,~9S;;.?~.·'·', " ,; , 
maternal age 'below 25 yeaft C~til:g.& " C.lI0~'" 
4.06). While the biololitilf~sm;',~i;il~ct~ 
trichomoniasis with' HIV"~ 'i&not'~, it; Is 
possible that this is a surrogate 'fc:n-' 'otlt~ratagno~d 
STDs or high risk sexual actiVity In g~~raI. The finding 
that condom usage is a risk factor for seroconversion 
runs contrary to conventional understanding of the 
role of condoms in preventing HIV infection. A likely 
explanation is that wome'ildid not use condoms con-
sistently or condom use is only a marker of high risk 
behaviours. Data on incident HIV-I infection in spe-
cific populations are critical to monitor epidemic 
trends, identify modifiable risk factors and plan inter-
ventions such as vaccine clinical trials'. 
Knowledge. attitudes. beliefs and practices (KABP). 
Based on STDs incidence and reported sexual history, 
HIV-I seropositive women appeared more likely than 
HIV-I seronegative women to over-report consistent con-
dom use. Similarly, both seropositive and seronegative 
women under-reported sexual activity. These findings 
suggest that reported condom use is less reliable in 
seropositive than in seronegative women. Reported con-
dom use and sexual history, variables commonly used in 
program evaluation, should be validated with biologic 
markersl6• 
To evaluate knowledge and attitudes over time 688 
HIV-I seropositive and 690 HIV-I seronegative women 
Malawi Medical Journal. January 1994. Vol. 10. No 1 
were counselled and educated onseveral issues regarding 
coping with effects of AIDS, condom use and means of 
minimizing transmission. There was improvement in 
knowledge over time but some problems regarding 
routes of transmission were apparent especially among 
young and low socio-economic status mothers. Religion, 
high cost and lack of sexual pleasure were not the main 
barriers to condom usage. Appropriate education and 
counselling has a positive impact on knowledge of 
HIV / AIDS and should be carried outas often as possible, 
and antenatal care clinics provide a good opportunityl'. 
CONCLUSIONS 
The studies conducted on pregnant women in Blan-
tyre show that HIV-I seroprevalence has been rising 
over time. The rate of transmission from the mother 
to the infant is high in this population. HIV-I infection 
of the mother substantially contributes to fetal wastage 
and to the high levels of in fan t and childhood mortality 
in Malawi. HIV-I seropositive mothers are more sus-
ceptible 'to other STDs and show immunological de-
rangements similar to that of women from developed 
countries l8. The findings justify the health and socio-
demographic concerns if the current situation prevails. 
Several factors with significant policy implications have 
been, identified and could be considered in interven-
tion programs to reduce transmission of the virus in 
the country. AlthQugh our investigation, by design, 
excludes male partners who also contribute to this 
. epidemic. their role in sustaining the epidemic should 
'not beunderUtimated. '.11letefore' effective interven-
tibn 'idNlties ~htfuldhave rio 'gender restrictions. Pre-
;~~' of 'STo.;i indudinga:dequate clinioAl services · .il,!~~~ &i1d treatment, is a prioritfldentified by 
,<~~O~16ba1 Program on AIDS for many countries 
<lf90~ah8ran Africa and confirmed by these studies 
in Malawi. All segments and economic strata of the 
t>dpulation should be targeted by educational mes-
s~es. For pregnant women, the antenatal clinic is a 
reaSonable setting but has obvious limitations. In a 
situation where the prevalence of HIV-I is high, it 
would be appropriate to disseminate the information 
to adolescent girls and nonpregnant women. The rate 
of new HIV-I infection increases after delivery and is 
associated with modifiable behaviours, ~aking the 
postpartum period an appropriate time to consider for 
STD control, educational programs and HIV / AIDS 
vaccine trials. In this direction, the JHU-MOH project 
has begun an extended study on preparation for 
AIDS/HIV vaccine evaluation (PAVE) among pregnant 
women. Until a globally firm intervention strategy is 
reached, conventional measures such as appropriate 
counselling, education, diagnosis and treatment of STDs, 
and promotion of condom use are recommended. 
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